Diagnostic gastroenterology

Freenome’s Multiomics Blood Test Shows Promising Results in Detecting Colorectal Advanced Adenomas in a Prospective, Multi-Center Clinical Study

Tuesday, January 12, 2021 - 2:00pm

Compared with the FDA-approved mSEPT9 (methylated septin 9) blood test, Freenomes multiomics blood test showed much higher sensitivity (41% vs. 22%)1 for detecting AAs.

Key Points: 
  • Compared with the FDA-approved mSEPT9 (methylated septin 9) blood test, Freenomes multiomics blood test showed much higher sensitivity (41% vs. 22%)1 for detecting AAs.
  • That means with a blood test such as Freenomes multiomics test, not only can we detect colorectal cancer, but we may be able to prevent colorectal cancer altogether.
  • A blood test that can detect both advanced adenomas and early stage colorectal cancer could be an important tool in the fight against colorectal cancer.
  • Importantly, these new results also showed that Freenomes multiomics blood test detected twice as many advanced adenomas as cell-free DNA methylation-only or single-protein approaches.

NEC Releases 'WISE VISION Endoscopy' in Europe and Japan

Tuesday, January 12, 2021 - 1:56am

TOKYO, Jan 12, 2021 - (JCN Newswire) - NEC Corporation (TSE: 6701) has announced the development of "WISE VISION Endoscopy," an AI diagnosis-support medical device software for colonoscopies, which is being released in Japan today and is expected to soon be available in Europe.

Key Points: 
  • TOKYO, Jan 12, 2021 - (JCN Newswire) - NEC Corporation (TSE: 6701) has announced the development of "WISE VISION Endoscopy," an AI diagnosis-support medical device software for colonoscopies, which is being released in Japan today and is expected to soon be available in Europe.
  • This software connects with existing endoscopy equipment as part of using AI to automatically mark potential lesions from images taken during endoscopic procedures.
  • Colorectal cancer is the most common cancer in Japan(1), and the second most common in Europe(2).
  • NEC has been working with the National Cancer Center Japan since 2016 to contribute to resolving this issue.

NEC Releases “WISE VISION Endoscopy” in Europe and Japan

Tuesday, January 12, 2021 - 1:00am

NEC Corporation (NEC; TOKYO: 6701) today announced the development of WISE VISION Endoscopy, an AI diagnosis-support medical device software for colonoscopies, which is being released in Japan today and is expected to soon be available in Europe.

Key Points: 
  • NEC Corporation (NEC; TOKYO: 6701) today announced the development of WISE VISION Endoscopy, an AI diagnosis-support medical device software for colonoscopies, which is being released in Japan today and is expected to soon be available in Europe.
  • This software connects with existing endoscopy equipment as part of using AI to automatically mark potential lesions from images taken during endoscopic procedures.
  • View the full release here: https://www.businesswire.com/news/home/20210111006087/en/
    Colorectal cancer is the most common cancer in Japan (*1), and the second most common in Europe (*2).
  • NEC has been working with the National Cancer Center Japan since 2016 to contribute to resolving this issue.

Micro-Tech Endoscopy Reveals NEW Pro-Trap Luma

Monday, January 11, 2021 - 2:37pm

ANN ARBOR, Mich., Jan. 11, 2021 /PRNewswire/ -- Micro-Tech Endoscopy USA is excited to kick off the year with its first new product of 2021.

Key Points: 
  • ANN ARBOR, Mich., Jan. 11, 2021 /PRNewswire/ -- Micro-Tech Endoscopy USA is excited to kick off the year with its first new product of 2021.
  • The ProTrap Luma Polyp Trap is designed to limit the handling of specimens with touch-less sample retrieval.
  • The ProTrap Luma consists of a collection vessel with magnifying window for better visualization, specimen collection strainer and glow stick for enhanced visualization in dark rooms.
  • Micro-Tech Endoscopy has operations in America, Asia, and Europe and leverages this global reach to refine the products we provide to our partners.

Motus GI Expands Intellectual Property Portfolio with U.S. Patent for the Pure-Vu® System’s Universal Method to Mount on the End of Most Commercial Colonoscopes

Monday, January 11, 2021 - 12:45pm

The commercial potential of our system is more apparent than ever as our U.S. sales program continues to successfully build awareness for the Pure-Vu System among leading U.S. gastroenterologists and hospital systems.

Key Points: 
  • The commercial potential of our system is more apparent than ever as our U.S. sales program continues to successfully build awareness for the Pure-Vu System among leading U.S. gastroenterologists and hospital systems.
  • The United States Patent Office issued patent 10,881,277, which is titled Distal Front End for Coordinated Portioning of an Endoscope with Suction Device.
  • Motus GI estimates that approximately four million inpatient colonoscopy procedures take place worldwide each year.
  • The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

SOLVD Health Prepares to Launch Clinical Study of Non-Invasive Colorectal Cancer Screening Test

Wednesday, January 6, 2021 - 7:00pm

CARLSBAD, Calif., Jan. 6, 2021 /PRNewswire/ -- SOLVD Health ( www.solvdhealth.com ), a privately held company focused on preventing disease by making actionable and contextual health information accessible to everyone, is preparing to launch a U.S. clinical study of its non-invasive colorectal cancer (CRC) screening test, LifeKit Prevent.

Key Points: 
  • CARLSBAD, Calif., Jan. 6, 2021 /PRNewswire/ -- SOLVD Health ( www.solvdhealth.com ), a privately held company focused on preventing disease by making actionable and contextual health information accessible to everyone, is preparing to launch a U.S. clinical study of its non-invasive colorectal cancer (CRC) screening test, LifeKit Prevent.
  • "Colonoscopy is the current gold standard for colorectal cancer screening because it accurately detects cancer as well as precancerous adenomas," said Keri Donaldson , MD, CEO of SOLVD Health.
  • Early research has shown that our test is effective at detecting both, which could be a gamechanger for colorectal cancer screening."
  • SOLVD Health's prospective clinical trial will enroll up to 12,000 individuals to validate its test for the detection of colorectal cancer and adenomas.

KARL STORZ Announces Breakthrough Imaging Technology

Tuesday, January 5, 2021 - 5:36pm

KARL STORZ Endoscopy-America, Inc., a leader in minimally invasive surgical technology and related medical systems, announces the latest advancement in endoscopic imaging.

Key Points: 
  • KARL STORZ Endoscopy-America, Inc., a leader in minimally invasive surgical technology and related medical systems, announces the latest advancement in endoscopic imaging.
  • View the full release here: https://www.businesswire.com/news/home/20210105005791/en/
    The IMAGE1 S Rubina endosurgical visualization system from KARL STORZ combines state-of-the-art 4K resolution with enhanced fluorescence-guided imaging.
  • Rubina is yet another game-changing technology that is a modular add-on to the IMAGE1 S system from KARL STORZ.
  • KARL STORZ Endoscopy-America, Inc., is an affiliate of KARL STORZ SE & Co. KG, an international leader for 75 years in advanced medical technology, providing surgical and procedural imaging, instrumentation, and enterprise-wide integration.

Micro-Tech Endoscopy and Interscope Announce Partnership & Extended FDA Clearance for EndoRotor® System

Wednesday, December 30, 2020 - 4:28pm

ANN ARBOR, Mich., Dec. 30, 2020 /PRNewswire/ -- Micro-Tech Endoscopy and Interscope inked a partnership agreement to collaborate and distribute the EndoRotor System for interventional gastroenterology.

Key Points: 
  • ANN ARBOR, Mich., Dec. 30, 2020 /PRNewswire/ -- Micro-Tech Endoscopy and Interscope inked a partnership agreement to collaborate and distribute the EndoRotor System for interventional gastroenterology.
  • Our innovative product, paired with the driving force of Micro-Tech, will dramatically accelerate physician access to the EndoRotor and the benefits it provides," explains Jeffery Ryan, Co-Founder, President, and CEO of Interscope, Inc.
    Interscope and Micro-Tech Endoscopy signed a partnership agreement for distribution of the unique EndoRotor System.
  • "Our shared drive to deliver innovation to customers brought Micro-Tech Endoscopy and Interscope together," says Chris Li, President of Micro-Tech Endoscopy USA.
  • This extended clearance makes the EndoRotor the first FDA-cleared device used in DEN for WOPN/WON.

Worldwide Endoscopy Devices Industry to 2027 - Unmet Medical Demands in Developing Countries Present Opportunities

Tuesday, December 29, 2020 - 2:45pm

Endoscopy is a minimally invasive medical procedure used for diagnosis, prevention, and treatment of complications in visceral organs.

Key Points: 
  • Endoscopy is a minimally invasive medical procedure used for diagnosis, prevention, and treatment of complications in visceral organs.
  • On the contrary, unmet medical demands in developing countries and lucrative opportunities in emerging economies are expected to create immense opportunities for endoscopy devices manufacturers worldwide in the future.
  • The other endoscopy equipment is further fragmented into insufflators, endoscopy fluid management systems, and other electronic endoscopy equipment.
  • By application, it is classified into bronchoscopy, arthroscopy, laparoscopy, urology endoscopy, neuroendoscopy, gastrointestinal endoscopy, gynecology endoscopy, ENT endoscopy, and others.

Global Capsule Endoscopes Market Analysis During 2020-2024|Industry Research Report From Technavio

Monday, December 28, 2020 - 10:30pm
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20201228005299/en/
    Technavio has announced its latest market research report titled Global Capsule Endoscopes Market 2020-2024 (Graphic: Business Wire)
    Worried about the impact of COVID-19 on your business?
  • The report on the capsule endoscopes market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
  • The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment.
  • This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters
    The Capsule Endoscopes Market covers the following areas: